Filtered By:
Specialty: Pharmaceuticals
Education: Lessons
This page shows you your search results in order of date.
Order by Relevance | Date
Total 38 results found since Jan 2013.
InnovationRx: The Lessons ‘Oppenheimer’ Holds For Biotech
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: Forbes.com Healthcare News - July 26, 2023 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Science /science Venture Capital /venture-capital AI /ai Editors' Pick editors-pick Newsletter No Paywall no-paywall Coronavirus premium Source Type: news
Leveraging electronic logistics management information systems to enhance and optimize supply chain response during public health emergencies: lessons from COVID-19 response in Uganda
ConclusionsAvailability of reliable, quality real-time data are essential for effective decision making during public health emergencies. The emergency Electronic Logistic Management Information Systems supported health authorities to mount coordinated and effective responses to ensure timely availability of commodities and supplies to support the COVID-19 pandemic response. Lessons learnt from the Ebola epidemic response were translated into actions that enabled effective preparedness and response to the COVID-19 pandemic.
Source: Journal of Pharmaceutical Policy and Practice - January 17, 2023 Category: Pharmaceuticals Source Type: research
What Dr. Anthony Fauci Teaches Us About Leadership In A Crisis
Dr. Anthony Fauci ’s numerous and extended trials by fire over the past 38 years provide corporate executives with important lessons about leadership in a crisis.
Source: Forbes.com Healthcare News - December 5, 2022 Category: Pharmaceuticals Authors: Edward Segal, Senior Contributor Tags: Leadership Strategy /leadership-strategy Business /business Innovation /innovation Healthcare /healthcare Coronavirus Editors' Pick editors-pick Source Type: news
Protecting against influenza: A conversation with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus
Our industry is at the forefront of fighting the annual influenza virus. I recently had the chance to connect with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus about how the industry is working to fight the annual flu and what lessons learned during COVID-19 are allowing us to better respond to influenza.
Source: The Catalyst - October 13, 2022 Category: Pharmaceuticals Authors: Mike Ybarra Tags: PhRMA Member Company Vaccines Infectious Diseases Coronavirus Source Type: news
ICYMI: New research builds upon growing body of evidence on value of COVID-19 treatments and vaccines
Innovative biopharmaceutical research companies have been dedicated to fighting COVID-19 for over two years. Since the start of the pandemic, America ’s biopharmaceutical companies have worked around the clock to research, develop and manufacture treatments and vaccines to fight COVID-19. We’ve made unprecedented progress in a short time thanks to decades of experience having produced over 14 billion vaccines globally to date. What’s more,lessons learned during the pandemic are already informing the future of fighting disease.
Source: The Catalyst - August 16, 2022 Category: Pharmaceuticals Tags: Research and Development Economic Impact Intellectual Property Coronavirus Source Type: news
ICYMI: PhRMA CEO Stephen J. Ubl spotlights lessons learned during COVID-19
This week, PhRMA sponsored The Washington Post ’s event,Coronavirus: Lessons of the Pandemic, where PhRMA president and CEO Stephen J. Ubl shared cruciallessons learned from the pandemic on how to protect patient access to medicine and ensure the health of our robust supply chain. The event also featured PhRMA board member and Genentech CEO Alexander Hardy, who discussed Genentech ’s progress during the pandemic and how to improvehealth equity.
Source: The Catalyst - May 13, 2022 Category: Pharmaceuticals Tags: Drug Cost Coronavirus Antimicrobial Resistance Source Type: news
ICYMI: New resource catalogs biopharmaceutical industry lessons learned from COVID-19
Since the start of the pandemic, America ’s biopharmaceutical companies haveworked around the clock to research, develop and manufacture treatments and vaccines to fight COVID-19. We ’ve made unprecedented progress with having delivered over 12 billion vaccines globally with another 20 billion expected in 2022.
Source: The Catalyst - April 28, 2022 Category: Pharmaceuticals Authors: Gabby Migliara Tags: Research and Development PDUFA Coronavirus Antimicrobial Resistance Source Type: news
Six Lessons From Covid To Remember For Future Pandemic Preparedness
Infectious disease expert Dr. Mark Kortepeter warns that we cannot have short pandemic memories and must continue to invest in public health infrastructure, education and science so that the cycle doesn ’t repeat.
Source: Forbes.com Healthcare News - March 31, 2022 Category: Pharmaceuticals Authors: Mark Kortepeter, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus Source Type: news
Pfizer CEO Albert Bourla, Dr. Anthony Fauci Discuss Lessons From The Holocaust
As the CEO of Pfizer, Albert Bourla made headlines for his professional accomplishments, but few know about his family history.
Source: Forbes.com Healthcare News - April 7, 2021 Category: Pharmaceuticals Authors: Jair Hilburn, Contributor Tags: Diversity, Equity & Inclusion /diversity-equity-inclusion Leadership /leadership Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick Coronavirus Source Type: news
These Four Policy Changes Could Help Us Get Vaccines For The Next Pandemic Even Faster
Public health experts Eric A. Friedman, Lawrence O. Gostin, Sarah A. Wetter explore how lessons learned from producing vaccines during the Covid-19 pandemic could make the response to the next pandemic even faster.
Source: Forbes.com Healthcare News - March 2, 2021 Category: Pharmaceuticals Authors: Lawrence Gostin, Contributor Tags: Healthcare /healthcare Innovation /innovation Policy /policy Editors' Pick editors-pick Coronavirus Source Type: news
Lessons learned from COVID-19: The way we develop new medicines is changing
The COVID-19 pandemic has affected nearly every aspect of society, including the way scientists conduct the testing of medicines.
Source: The Catalyst - February 10, 2021 Category: Pharmaceuticals Authors: Richard Moscicki, M.D. Tags: Research and Development & D Focus Coronavirus Source Type: news
Ebola, Covid-19 And The Elusive Quest For Global Health Equity
Published during this pandemic, Paul Farmer ’s new book, “Fevers, Feuds, And Diamonds,” is important, as it presents a critical dissection of the Ebola outbreak in West Africa, and the lessons we can learn from Ebola today, even as we struggle to contain the Covid-19 pandemic.
Source: Forbes.com Healthcare News - February 8, 2021 Category: Pharmaceuticals Authors: Madhukar Pai, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Coronavirus Source Type: news
For Insight On New Covid-19 Variants, Look To Natural History Of Coronaviruses
Though the human coronavirus 229E isn ’t nearly as hot a topic as SARS-CoV-2 these days, it is one of several coronaviruses that have been causing us colds for more than half a century. It also has lessons to teach us about the ability of coronaviruses to evolve and evade immunity over time.
Source: Forbes.com Healthcare News - January 21, 2021 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
How We See Data And How We Act: Lessons From The Covid-19 Pandemic
A new study looks at how public knowledge, the perception of risk, and behavioral intentions are influenced (or not) by the data one sees.
Source: Forbes.com Healthcare News - January 13, 2021 Category: Pharmaceuticals Authors: John Drake, Contributor Tags: Science /science Innovation /innovation Healthcare /healthcare Coronavirus Source Type: news
Lessons From Covid-19 Can Prepare Us For The Next Pandemic
Public health experts Sarah Wetter and Lawrence Gostin explain how the lessons of Covid-19 can better prepare us for the next pandemic.
Source: Forbes.com Healthcare News - January 13, 2021 Category: Pharmaceuticals Authors: Sarah Wetter, Contributor Tags: Healthcare /healthcare Innovation /innovation Editors' Pick editors-pick Coronavirus Source Type: news
